Trying one antidepressant after another without getting the relief you hoped for can leave you wondering why your depression has been so difficult to treat and what options are left.
When depression symptoms persist despite adequate antidepressant treatment, you may be experiencing treatment-resistant depression. This does not mean depression cannot be treated. It may mean it is time to consider a treatment that works differently.
Transcranial magnetic stimulation (TMS) therapy is a non-invasive brain stimulation treatment that may be considered when antidepressant medication has not provided sufficient relief. Rather than introducing another medication, TMS uses magnetic pulses to influence activity within brain networks involved in depression.
Quick answer: Can TMS therapy help when antidepressants haven’t worked?
Yes. TMS therapy may help some people with depression who have not experienced adequate improvement with antidepressant medication. In fact, inadequate response to antidepressant treatment is one of the circumstances in which TMS is commonly considered.
TMS works differently from medication by using magnetic stimulation to influence targeted brain activity. However, response varies, and previous medication failure does not guarantee that TMS will be effective.
A clinical evaluation can help determine whether TMS therapy may be appropriate for you.
Why antidepressants don’t work for everyone
Antidepressants are an important and effective treatment for many people with depression, but no single medication works for everyone.
The landmark STAR*D study, funded by the National Institute of Mental Health, followed patients through multiple treatment steps when their depression did not remit with an initial antidepressant. The research demonstrated an important clinical reality: some patients achieve remission with the first medication they try, while others require additional treatment strategies, and the likelihood of remission generally decreases with each successive treatment step.
The findings helped establish the need for multiple evidence-based approaches to depression when an initial medication is not enough.
There are many possible reasons an antidepressant may not provide sufficient relief.
Depression is a complex condition involving biological, psychological and environmental factors, and people can differ in their symptoms, treatment history and response to medication.
A lack of response does not necessarily tell you why a particular antidepressant did not work. It does, however, provide useful clinical information when your treatment team considers what to try next.
If adequate medication trials have not produced sufficient improvement, your clinician may discuss changing medication, psychotherapy, combination treatment, brain stimulation or other approaches based on your individual circumstances.
How TMS therapy works when medication hasn’t
Antidepressants and TMS approach depression differently.
Medication is taken systemically and affects biological processes associated with depression throughout the body and brain. TMS does not require medication to reach the brain through the bloodstream. Instead, it uses a magnetic field generated outside the head to induce electrical activity in targeted brain tissue.
For depression, conventional TMS therapy commonly targets an area of the prefrontal cortex involved in mood-related brain networks.
Repeated stimulation can influence activity within those networks over the course of treatment. Because this mechanism is different from antidepressant medication, a previous lack of response to medication does not necessarily mean you will not respond to TMS therapy.
That distinction is one reason TMS therapy may be considered for people whose symptoms have persisted despite antidepressant treatment.
At Neurotherapeutix, fMRI-guided TMS therapy adds individualized functional brain imaging and computational analysis to this process.
If you are specifically exploring treatment for persistent depression, you can also learn more about TMS therapy for depression and how Neurotherapeutix approaches treatment planning.
Why fMRI-guided TMS therapy offers a more individualized approach
Standard TMS therapy typically identifies a stimulation target using standardized anatomical measurements or scalp-based landmarks. This allows clinicians to target a general brain region associated with the condition being treated.
Neurotherapeutix takes a different approach.
Before treatment begins, resting-state functional magnetic resonance imaging (rsfMRI) measures patterns of activity and communication across functional networks throughout your brain.
Our patented computational brain mapping technology then analyzes those connectivity patterns to identify individualized areas of interest based on your functional brain organization.
The fMRI analysis identifies individualized areas of brain tissue with functional patterns relevant to the patient’s symptoms. These targets are uploaded into the neuronavigation system, allowing the treatment team to consistently and precisely position the TMS coil over the selected anatomical region with millimeter-level accuracy throughout therapy.
This means treatment planning is informed by how your individual brain is functioning rather than relying only on a standard treatment location.
For someone who has already tried several treatments without sufficient improvement, this may provide additional information not included in previous treatment planning.
However, personalized targeting does not guarantee a response to TMS therapy. The value of the approach is that it gives your clinical team an individualized view of functional brain connectivity that can help inform where treatment is delivered.
What the research says about TMS therapy after antidepressants fail
TMS has been studied extensively in depression, including among patients whose symptoms have not adequately improved with antidepressant treatment.
The FDA first cleared repetitive TMS for the treatment of major depressive disorder in adults who had not achieved satisfactory improvement from a prior antidepressant medication in the current depressive episode. Since then, TMS technologies and indications have continued to evolve.
Clinical research has found that some patients with treatment-resistant depression experience a meaningful reduction in symptoms with TMS, and some achieve remission.
Response rates vary among studies because patient populations, treatment protocols, definitions of response and other factors differ.
The key point is not that TMS will work because antidepressants did not. It is that antidepressant nonresponse does not rule out the possibility of responding to a treatment that works through a different mechanism.
Is fMRI-guided TMS therapy right for you after failed medication?
If you have tried one or more antidepressants without sufficient improvement, fMRI-guided TMS therapy may be worth discussing with a qualified clinician.
Your evaluation should consider more than the number of medications you have tried. Your treatment team may review:
- Your diagnosis and current symptoms
- How long you have experienced symptoms
- Which antidepressants and other medications you have tried
- Whether those medications were taken at adequate doses and for adequate lengths of time
- Your response to psychotherapy or other treatments
- Previous TMS or other brain stimulation treatment
- Your medical and neurological history
- Current medications and potential safety considerations
You can learn more about TMS therapy candidacy and the factors Neurotherapeutix considers before recommending treatment.
Having treatment-resistant depression does not automatically make someone a candidate for TMS, and TMS is not appropriate for everyone. An individualized clinical evaluation is the best way to determine whether it may fit into your treatment plan.
Frequently asked questions
Have additional questions about treatment, side effects or what to expect? Visit our frequently asked questions for more information about fMRI-guided TMS therapy at Neurotherapeutix.
Is TMS therapy effective if antidepressants didn’t work?
It can be.
TMS is an established treatment option for some patients with depression who have not experienced adequate improvement with antidepressant medication.
However, treatment response varies, and previous antidepressant failure does not predict with certainty whether an individual patient will respond to TMS.
How is TMS therapy different from taking another medication?
The treatments work through different mechanisms.
Antidepressant medications affect biological processes associated with depression through pharmacological action. TMS uses magnetic pulses delivered from outside the head to influence activity in targeted areas of the brain and connected networks.
TMS is also non-invasive and does not require surgery or anesthesia.
Do I need to stop my current medication to try fMRI-guided TMS therapy?
Not necessarily.
Many patients receive fMRI-guided TMS therapy while continuing antidepressant or other psychiatric medication. Whether you should continue, change or discontinue a medication depends on your individual treatment plan.
Your clinician should review all medications before TMS begins because certain medications or recent medication changes may affect treatment planning or seizure risk.
Do not stop an antidepressant or change your dose on your own in preparation for TMS.
Abruptly discontinuing some antidepressants can cause withdrawal symptoms or other problems.
How soon can I start TMS therapy after stopping antidepressants?
There is no universal waiting period because you do not necessarily need to stop antidepressants before beginning TMS.
If you and the clinician managing your medication decide to reduce or discontinue a medication, the appropriate timeline depends on the specific medication, dose, how long you have been taking it, and your individual medical circumstances.
Your Neurotherapeutix team will review your current and recent medications during your evaluation and coordinate treatment planning accordingly.
Explore a different approach to persistent depression
If antidepressants have not given you the relief you hoped for, another medication is not necessarily your only next step.
Neurotherapeutix is the only clinic in the United States offering its patented fMRI-guided TMS therapy. Our approach combines whole-brain functional imaging, computational brain mapping, individualized targeting and neuronavigation to personalize treatment based on your individual brain function.
Our team can review your treatment history, discuss whether fMRI-guided TMS therapy may be appropriate and help you understand what an individualized treatment plan could look like.
Request an appointment today to learn more and get started.
